Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION.  Partnering the NVIDIA A100 Tensor Core GPU technology with the PromethION device aims to deliver the world’s most powerful sequencer that supports real-time analyses at scale, and can also analyse any [...]

Partnership to Accelerate Adoption of Next-Generation Sequencing (NGS) in Clinical Decision-Making Comprehensive Pan-Cancer Tumor Profiling Assays can be Combined with Clinical Informatics Platform with Potential to Reduce Time to Results and Complexity of Clinical Genomic Analysis Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, announced today that it has entered into a collaboration [...]

BOSTON -- NanoView Biosciences, Inc., the leader in single exosome characterization, today announced the expansion of its management team with the appointment of David Hanlon, Ph.D. to the position of Vice President, Strategic Collaborations.   The addition is a key part of the company's strategy to create and expand strategic partnerships within the life sciences, pharmaceutical and diagnostics [...]

Growth-Oriented Private Equity Firm SFW Partners with Leading Provider of Laboratory Equipment to Drive Growth Through Expansion of Product Portfolio and Strategic Acquisitions RYE, N.Y. – SFW Capital Partners (“SFW”), a specialized private equity firm that invests in leading providers of instrumentation, laboratory products, software/information and related solutions, today announced that it has completed a [...]

CALGARY, AB - Nanalysis Scientific Corp. ("Nanalysis"),((NSCI) ((NSCIF) (FRA: 1N1), through its subsidiary RS2D S.A.S. ("RS2D"), is pleased to announce that it has signed multi-million dollar OEM and licensing deal with a European corporation. Rémy Schimpf, Senior VP Sales states "The deal includes an initial payment of roughly $1 million, and a further $2 million in milestone payments over the next [...]

The BD® AbSeq Immune Discovery Panel enables researchers to execute single cell experiments with high efficiency FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD® AbSeq Immune Discovery Panel (IDP), a state-of-the-art, pre-titrated antibody-oligo based discovery tool designed to investigate 30 immune [...]

Acquisition expands Cole-Parmer’s portfolio of life sciences tools and reference standards Chicago, IL and Vernon Hills, IL – GTCR, a leading private equity firm, announced today that its Cole-Parmer (“CP”) portfolio company has acquired ZeptoMetrix Corporation (“ZeptoMetrix”).  ZeptoMetrix is a life sciences developer and manufacturer of quality control standards and verification panels used in molecular [...]

Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub SAN DIEGO, Calif. – Jumpcode Genomics – a genome technology company focused on improving the understanding of human [...]

Company to Accelerate Mass Manufacturing and Commercialization of Proprietary PCR-Free Multi-Omics Technology Following Year of Rapid Growth Cardea Bio, Inc., a Tech+Bio company integrating molecular biology with semiconductors via Graphene-based biology-gated Transistors, announced today a $6.5M series A extension that brings the A round total above $20M. The new capital infusion is led by the [...]

Transaction Represents Vance Street’s Second Investment out of its Third Fund Vance Street Capital LLC (“Vance Street”), a Los Angeles-based private equity firm, today announced the acquisition of Excel Scientific, Inc. (“Excel”), a leading manufacturer of microplate sealing films and foils used by life science research, university, and testing laboratories as well as biotech companies, [...]